Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
It is not licensed as a weight loss pill in the United Kingdom, and it is important to understand its intended clinical uses before considering it in any other context
A systematic review and meta-analysis of clinical trials reported that patients treated with GLP-1 receptor agonists experienced greater improvements in depression scores compared with control groups
As a potential target for treatment development, MOTS-c is expected to be used in the treatment development of a variety of diseases
In contrast, insulin can sometimes lead to weight gain due to its role in glucose storage
Ideal Candidates Include: Adults with a BMI of 30 or above (classified as clinically obese) Adults with a BMI of 27 or above alongside at least one weight-related health condition such as type 2 diabetes, high blood pressure, or dyslipidaemia People who have not achieved enough weight loss through diet and exercise alone Individuals living with metabolic syndrome or pre-diabetes Patients who have stopped seeing results from other weight loss medications What Are the Contraindications for Retatrutide
This product is supplied as a lyophilized powder for controlled laboratory research only
